Press Releases
March 15, 2023
Predictmedix Announces Production of AI-Powered Mobile Application to Rapidly Detect Impairment from Alcohol and Cannabis
Predictmedix has begun production of its mobile application for detecting impairment from cannabis and alcohol Predictmedix’s screening to identify impairment takes less than 30 seconds The mobile application, powered by AI algorithms currently being…
Read full release →March 08, 2023
Predictmedix Announces Completion of 1600-Person Clinical Study for Safe Entry’s Medical Device Regulatory Approval in Indonesia
The 1600-person study at a prestigious University in Jakarta, Indonesia prepares Predictmedix’s Safe Entry for regulatory approval listed as a ‘Medical Device’ Medical device classification allows Predictmedix to commercialize Safe Entry at scale in…
Read full release →March 06, 2023
Predictmedix Announces a Purchase Order for Safe Entry’s Fit for Duty Screening in the Defence Sector
DefSpace, a global platform for Defence, Space and Aerospace will lease four Safe Entry Stations over four-year term primarily utilizing Safe Entry’s impairment detection screening Each of the four Safe Entry Station’s to generate…
Read full release →February 15, 2023
Predictmedix Announces Third-Party Independent Clinical Validation for AI-Powered Screening following 400 Patient Study at MGM Healthcare
Toronto, Ontario, February 15, 2023 – Predictmedix Inc. (“Predictmedix” or the “Company”) (CSE: PMED) (OTCQB: PMEDF) (FRA:3QP), an emerging provider of rapid health screening solutions powered by a proprietary artificial intelligence (AI), today announced pivotal…
Read full release →February 13, 2023
Predictmedix Closes $612,500 Private Placement and Announces Listing on the Frankfurt Exchange
Toronto, Ontario, February 13, 2023 – Predictmedix Inc. (“Predictmedix” or the “Company”) (CSE: PMED) (OTCQB: PMEDF), an emerging provider of rapid health screening solutions powered by a proprietary artificial intelligence (AI), today announces that it…
Read full release →